INTRODUCTION
Extracellular matrix (ECM) is composed of proteoglycans interwoven with matrix
metallo proteins such as collagen, elastin and fibronectin. Collagen is the
major structural protein provides supportive framework to the cell. Elastin
maintains skin elasticity and resilience (Oikarinen, 2004).
Hyaluronic Acid (HA) holds the water together and keeps body smooth, moist and
lubricated.
During ageing, elasticity of the skin is decreased due to enzyme elastase which
leads to sagging. At the same time, the amount of hyaluronic acid in the skin
also diminishes and skin becomes dry and wrinkled. In the connective tissue
fibroblasts are the cells which synthesize collagen and other important matrix
metallo proteins. Proliferation and migration of these dermal fibroblasts suppresses
ageing by producing more matrix metallo proteins. In young and healthy skin,
the balance between synthesis and degradation of these proteins is maintained
(Aslam et al., 2005). But this intricate balance
gets disturbed as we age. For maintaining youthful skin, when production of
metallo proteins is not enough, the best way is to conserve them and the best
way to preserve them is by inhibition of matrix metallo proteinases (MMPase)
(Aslam et al., 2005).
Enzyme hyaluronidase degrades hyaluronic acid by lowering its viscosity and
increasing the permeability. It is found in human organs, body fluids and secretions
of viruses, fungi, bacteria, leeches and also in venoms of snakes, bees, lizards,
spiders etc. Hyaluronidase not only contributes in the destruction of ECM but
also plays a vital role in many biological and physiological processes such
as embryogenesis, angiogenesis, inflammation, disease progression, wound healing,
bacterial pathogenesis, diffusion of systemic venoms and invasion of tumors
(Girish and Kemparaju, 2007).
Like hyaluronidase, elastase too contributes significantly in other activities.
Human neutrophil elastase (HNE) has broad substrate specificity capable of not
only enzymatic cleavage of elastin but also other ECM proteins such as collagen,
hyaluronan, laminin etc. Under normal physiological conditions, endogenous inhibitors
protect healthy tissue from damage but when impaired balance get disturbed,
it leads to variety of diseases such as lung disorders, cardiovascular disorders,
arthrosclerosis and cancer etc. (Kobayashi et al.,
2004).
There are certain plant metabolites have been shown to inhibit hyaluronidase
and elastase. Polyphenols from blackberry, quercetein, gallotanins, tannic acid,
ascorbic acid, glycyrrhizin from Glycirrizia glabra glycoproteins from
Withania somniferea and certain alkaloids are good hyaluronidase inhibitors
(Girish and Kemparaju, 2005) while Curcumin from
Curcuma longa (Chainani-Wu, 2003), procyanidins
from Vitis vinifera (Maffei-Facino et al.,
1994), phenols such as epi-catechin, resveratrol (Hrenn
et al., 2006) and flavonoids such as galangin, kaempferol, quercetein
and myricetin are potent elastase inhibitors (Kanashiro
et al., 2006). The PGG, a condensed tannin and ellagic acid are reported
to bound elastin and prevent its degradation (Isenburg et
al., 2007).
The plant G. indica selected for present work is endemic to Western
Ghats of India. Fruits are used to make attractive red colored beverage have
bilious action. It is anthelminthic and cardiotonic and used in the treatment
of piles, dysentery and tumors etc. Fruit rinds of G. indica contain
about 2.4% anthocyanins. Out of them two were identified as cyanindin 3-glucoside
and cyanindin 3-sambuboside (Krishnamurthy et al.,
1981). Garcinol, yellow colored pigment and cambogiol present in the fruit
rinds showed good antioxidant activity due to the presence of phenolic group
(Krishnamurthy et al., 1982) and earlier methanolic
extracts of fruit rinds of G. indica showed good hyaluronidase and elastase
inhibition (Sambhus, 2006). But no extensive work has
done yet on hyaluronidase and elastase inhibition activities of different fractions
of G. indica. The objective of the present study was to separate different
fractions from crude methanolic extract of fruit rinds of G. indica and
study their anti aging ability using hyaluronidase and elastase inhibition assay.
MATERIALS AND METHODS
Reagents and chemicals: This work was carried out in Department of Botany, V.G. Vaze College, Mumbai, India. The project duration was March 2006 to Feb 2009. The ripe fruits of G. indica were collected from Dr. Balasaheb Sawant Konkan Krishi Vidyapith, Dapoli, Maharashtra. The organic solvents used were of the analytical grade (Merck and Qualigen). Elastase type IV from porcine pancreas (14.1 mg/solid). N- Succinyl-Ala-Ala-Ala-p nitroanilide (SANA), Hyaluronidase Type I S from Bovine testes (7900 units mg-1 solid) and Hyaluronic acid, sodium salt from Human Umbilical cord-purchased from Sigma-Aldrich, USA. For hyaluronidase and elastase inhibition activity. Colorimetric measurements were performed on UV-visible Spectrophotometer (Varian 50 Cary).
Preparation of plant extracts
Preparation of methanolic extract: The methanolic extract was prepared by
immersing (20 g) of dried fruit rinds of G. indica in 200 mL of acidified
Methanol (2% Concentrated HCl). After a week the extract was poured in the evaporating
dish and methanol was removed from the extract by evaporation at room temperature
and dried extract was further used fractionation.
Separation of ethyl acetate fraction: One gram of ME was dissolved in 50 mL of D/W. To this 50 mL of ethyl acetate was added and two fractions were allowed to separate in a separating funnel for at least 1 h. This was repeated twice. Both the fractions were completely dried at room temperature yielding 500 mg of WF and 300 mg of EAF.
Thin layer chromatography analysis: The ME, EAF and WF were analyzed by thin layer chromatography. Solvent system standardized was Butanol: Acetic acid: water (4:1:2).
Determination of hyaluronidase inhibition: Hyaluronidase inhibition
was determined by measuring the amount of N-acetylglucosamine splited from sodium
hyaluronate by the method described by Lee and Choi (1999a)
with slight modifications. Fifty microliter of bovine hyaluronidase (7900
units mL-1) dissolved in 0.1 M acetate buffer (pH 3.6) was mixed
with 50 μL of designated concentrations of ME, EAF and WF dissolved in
5% DMSO. The control group was treated with 50 μL of 5% DMSO instead of
extracts and was incubated for 20 min at 37°C. After 20 min 50 μL of
calcium chloride (12.5 mM) was added to the reaction mixture and again incubated
for 20 min at 37°C. This Ca2+ activated hyaluronidase was treated
with 250 μL sodium hyaluronate (1.2 mg mL-1) and incubated at
37°C for 40 min. After incubation 50 μL of 0.4 M sodium hydroxide and
100 μL of 0.2 M sodium borate were added to the reaction mixture and then
incubated in the boiling water bath for 3 min. After cooling to room temperature
1.5 mL of PDMAB solution (4 g PDMAB dissolved in 50 mL of 10N HCL and 350 mL
of glacial acetic acid) was added to the reaction mixture that was then incubated
in water bath at 37°C for 20 min when color developed. The absorbance was
measured at 585 nm on Varian Cary 50 UV spectrophotometer. All the analytical
data in the tables are the means of 3 determinations. Inhibitory effect was
expressed as follows:
Determination of elastase inhibition: Porcine pancreatic elastase (PPE,
Sigma, Type IV) was assayed spectrophotometrically using N-Succ-(Ala) 3-nitroanilide
(SANA) as the substrate, monitoring the release of p-nitroaniline by the method
described by Lee and Choi (1999b) with few modifications.
The reaction mixture contained 800 μL of 0.2 M Tris buffer (pH 8.0), 100
μL of enzyme elastase and 100 μL of 0.8 mM succ-(Ala) 3-nitroanilide
as substrate and different concentrations of plant extracts in Tris- HCl buffer.
Extract was preincubated with enzyme for 20 min at 25°C and the reaction
was started with the addition of substrate. In control, buffer was used in place
of the extracts. The absorbance was monitored at 410 nm for 20 min using UV
spectrophotometer. As a positive control we used A.catechu extract. Each
treatment was replicated thrice. Inhibitory effect of the extracts on the Elastase
activity was calculated as:
Statistical analysis: All assays were performed at least three times. Statistical analysis was performed using one way ANOVA followed by * which is significant at p< 0.05 (n = 3). Values given are Mean±SD.
RESULTS AND DISCUSSION
Thin layer chromatography: Methanolic extract comprised of many compounds that appeared to be violet, red, yellow and brown spots on TLC plates (Fig. 1). When methanolic extract was fractioned into EAF and WF, ethyl acetate fraction comprised of mainly yellow and brown pigments and water fraction contained majority of all pink and red colored pigments.
Hyaluronidase inhibition: Methanolic extract at low concentrations,
i.e., 250 μg mL-1 failed to produce noticeable hyaluronidase
inhibition. Concentrations in the range of 500 to 750 μg mL-1
produced significant inhibition (Table 1). At 750 μg
mL-1 it was 94% and then there was a decline at higher concentrations.
|
Fig. 1: |
Thin layer chromatogram of fractions separated from fruit
rinds of G. indica |
Table 1: |
Effect of various concentrations of ME separated from fruit
rinds of G. indica on hyaluronidase inhibition |
 |
Each value is expressed as Mean±SD of three replicate
determinations. Numbers followed by * are statistically significant at p<0.05
according to ANOVA (n = 3) |
Table 2: |
Effect of various concentrations of EAF and WF separated from
fruit rinds of G. indica on hyaluronidase inhibition |
 |
Each value is expressed as Mean±SD of three replicate
determinations. Numbers followed by * are statistically significant at p<0.05
according to ANOVA (n = 3) |
When ME was fractioned into EAF and WF, EAF at very low concentrations, i.e.,
25 μg mL-1 produced significant inhibition (88.33%) while water
fraction failed to produce any inhibition at such low concentrations. Ethyl
acetate fraction at a very broad range of concentrations 25 to 500 μg mL-1
produced significant hyaluronidase inhibition. Water fraction from concentrations
125 μg mL-1 showed effective inhibition (Table
2).
Elastase inhibition: In case of methanolic extract, the optimum range of elastase inhibition was 150 to 200 μg mL-1. At 200 μg mL-1 inhibition was 64.02%. After fractionation, EAF up to 150 μg mL-1 didnt produce any significant inhibition. At 250 μg mL-1 it was 73.02%. On the other hand, water fraction even at very low concentrations, i.e., 100 μg mL-1 onwards inhibited elastase (Fig. 2). Significant inhibition was seen at 200 μg mL-1 (81.02%) as compared to A. catechu which had 59% inhibition at same concentration.
Hyaluronidase mediated degradation of HA increases the permeability of the connective tissue and decreases the viscosity of the body fluids and is involved in the bacterial pathogenesis, spread of toxins and venoms. It facilitates the entry of sperm during invitro fertilization (IVF) and also involved in cancer progression.
Phenolic compounds such as quercetin, tannic acid acts as the inhibitors of
venom hyaluronidase (Girish and Kemparaju, 2005) or
inhibit sperm hyaluronidase (Garg et al., 2005).
Compounds like Apigenin, is known to inhibit tumor induced angiogenesis (Lokeshwar
et al., 2006). Similarly elastase released by neutrophils is physiologically
controlled by specific endogenous inhibitors such as α-antitrypsin, elafin
etc.
|
Fig. 2: |
Elastase inhibition assay of ME, EAF and WF separated from
the fruit rinds of G. indica |
The imbalance between elastase and its inhibitors is the cause of many inflammatory
diseases such as rheumatoid arthritis, pulmonary emphysema and acute lung injury.
As mentioned earlier, Pentagalloyl glucose (PGG), condensed tannin is reported
to bind with enzyme elastase and render resistance to elastase inhibitors in
arotic aneurysm and thus can be used as effective therapy in cardiovascular
disorders. The above description suggests the necessity of inhibition of these
two enzymes not only to prolong ageing but also to prevent the risk of such
fetal disorders.
As mentioned earlier, there are certain phenols and flavonoids which inhibit hyaluronidase
and elastase in dose dependant manner.
Lee et al. (2001)
showed that phenolic substances isolated from
A.catechu inhibited elastase
significantly (IC
50 ~ 26.92 μg mL
-1). Flavonoids and
triterpenoids separated from
Cornus kousa showed more than 50% elastase
inhibition at 100 μg mL
-1 while (IC
50 ~ 21.21 μg
mL
-1) (
Lee and Sultana, 2007). Similarly flavonoids
of
Achillea millefolium reported to be good elastase inhibitors. There
are various reports where polyphenols such as tannic acid, apigenin and quercetin
inhibited hyaluronidase activity significantly (
Girish and
Kemparaju, 2005). The above mentioned examples proved that polyphenols and
flavonoids could be used as potent antioxidants in anti ageing formulations.
Here in the present work we found out that crude methanolic extract at low
concentrations failed to inhibit hyaluronidase but was effective in bringing
out elastase inhibition. After fractionation into EAF and WF, EAF even at very
low concentrations inhibited hyaluronidase significantly (at 25 μg mL-1
it was 88.03% inhibition) while WF didnt had any effect on hyaluronidase
activity at such low concentrations. On the other hand, for elastase inhibition,
WF was more effective than that of EAF. The WF at 200 μg mL-1
produced significant elastase inhibition (81.02%) with that of A. catechu
(used as the positive control) had only 59% at same concentration.
Kumar et al. (2007) fractionated methanolic
extract of G. indica in to hexane, chloroform and ethyl acetate fraction
and showed that ethyl acetate fraction is the most toxic fraction against various
cell lines. Further they isolated two benzophenones namely xanthochymus and
isoxanthochymus from ethyl acetate fraction and studied their cytotoxicity.
CONCLUSION
This study reveals that among tested fractions, water fraction could be used as potential antioxidant and efforts are already underway to isolate and identify the compounds of water fraction which are responsible for bringing out such significant hyaluronidase and elastase inhibition and at the same time it will be less toxic to dermal fibroblasts.